| 摘要 |
The invention relates to novel crystalline forms of 3-beta-amino 17- methylene androstane-6-alpha 7-beta-diol hydrochloride, referred to as form A, form B and form C, a method for preparing same, the use thereof as a drug, and pharmaceutical compositions containing same. ® KIPO & WIPO 2007
|
